New Enterprise Associates

News, insights, analysis and data

← Back to New Enterprise Associates profile

New Enterprise Associates related stories

All articles and analysis

  • 500 Startups Ranks ahead of NEA, Accel as Most Active Investor in October
    Staff Writer- 1 December 2012

    The incubator announces its fall 2012 class and leads all VCs in deals during the month, having invested less than $1M combined

  • Rhythm Adds $8M to Cap Series B at $33M
    VCJ Staff- 27 November 2012

    Biopharma startup Rhythm has closed on an additional $8 million in Series B financing to cap the round at $33 million. The newest infusion comes from Pfizer Venture Investments, the venture capital arm of Pfizer. Pfizer joins existing investors MPM Capital, New Enterprise Associates, Third Rock Ventures, and Ipsen. The money will go toward development of the company’s “small-peptide therapeutics” for metabolic diseases.

  • New Enterprise Leads $20 Mln Round for Lattice Engines
    Luisa Beltran- 26 November 2012

    Lattice Engines said Monday it has raised $20 million in Series C funding led by New Enterprise Associates. Sequoia Capital, an existing investor, also participated. San Mateo, Calif.-based Lattice Engines provides cloud-based Big Data applications for sales and marketing.

  • Reuters: TiVo backer Redpoint raising $400 million fund
    Reuters News- 16 November 2012

    Redpoint Ventures, the venture-capital firm behind digital-video recording company TiVo and vacation-rental company HomeAway, is raising a $400 million fund, according to a person familiar with the matter.

  • Intarcia Therapeutics Completes $210M in Financings
    VCJ Staff- 16 November 2012

    Intarcia Therapeutics Inc., a privately held biotech company, has completed two financings totaling $210 million. The financing includes $160 million in preferred stock private placement and $50 million in debt financing. Investors include New Enterprise Associates, New Leaf Venture Partners, Venrock, The Baupost Group, and Farallon Capital Management.

  • Vuclip Closes $13M Series D
    VCJ Staff- 15 November 2012

    Vuclip, a mobile video and media company, has raised $13 million in Series D funding. SingTel Innov8 led the round, with participation from existing investors NEA and Jafco Ventures. Vuclip is based in Milpitas, Calif.

  • Cardioxyl Raises Series B Led By OrbiMed
    angela sormani- 14 November 2012

    Cardioxyl Pharmaceuticals has secured $28 million in a Series B financing led by OrbiMed Advisors. New investor Osage University Partners joined OrbiMed and returning investors New Enterprise Associates and The Aurora Funds in the financing.

  • Washington State Investment Chief Says Access to Top Venture Funds Remains Difficult
    Gregory Roth- 13 November 2012

    Limited access to top venture funds continues to restrain the Washington State Investment Board from investing in the asset class, according to Gary Bruebaker, the board’s chief investment officer.

  • Fund Performance: Washington State’s Venture Capital Hesitancy
    Mark Boslet- 12 November 2012

    NEA has one of the best performers in the state pension fund, while two OVP Venture Partners funds rank in the bottom

  • Orlando-based Pentaho Seals $23M
    VCJ Staff- 30 October 2012

    Business analytics company Pentaho Corp., has raised $23 million in Series C financing. New Enterprise Associates led the round, with participation from additional existing investors Benchmark Capital, Index Ventures and DAG Ventures. The money will to toward development, engineering, services, sales and marketing.